In their analysis, they observed that high TMB was only associated with better survival in the case of MSI- or POLD (POLE or POLD1)-mutated tumors, or in cancers highly related to environmental carcinogens (head and neck, lung, and melanoma). The gene discussed is POLE; the disease is melanoma.